Literature DB >> 9652326

Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: clinical utility of radionuclide imaging for differential diagnosis.

Y Yazaki1, M Isobe, M Hayasaka, M Tanaka, T Fujii, M Sekiguchi.   

Abstract

A 62-year-old woman with skin sarcoidosis was admitted to our hospital to ascertain whether she had cardiac involvement. Although she displayed no cardiac signs or symptoms, the electrocardiogram showed first-degree atrioventricular block, right bundle branch block with left anterior fascicular block, and giant negative T waves in the V3 lead. Echocardiography revealed marked hypertrophy localized in the basal portion of the interventricular septum (IVS) without systolic dysfunction, mimicking hypertrophic cardiomyopathy (HCM). Exercise thallium-201 myocardial imaging revealed redistribution in the anteroseptal region. Both gallium-67 (67Ga) and technetium-99m pyrophosphate (99mTc-PYP) scintigraphy revealed abnormal uptake in the myocardium. These findings disappeared after 2 months of steroid treatment. Reports of cardiac sarcoidosis mimicking HCM are rare. However, hypertrophy in the basal portion of the IVS is an important sign of early cardiac involvement in sarcoidosis. 67Ga and 99mTc-PYP scintigraphy were useful and necessary to differentiate this type of cardiac sarcoidosis from HCM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652326     DOI: 10.1253/jcj.62.465

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  6 in total

1.  Sarcoidosis and the Heart.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

Review 2.  Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines.

Authors:  Dae-Won Sohn; Jun-Bean Park; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim
Journal:  Clin Cardiol       Date:  2018-10-17       Impact factor: 2.882

3.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

Review 4.  18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Authors:  Hicham Skali; Allison R Schulman; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

5.  A case of cardiac sarcoidosis mimicking cardiac amyloidosis on cardiovascular magnetic resonance.

Authors:  Kazunori Takemura; Ryuta Nakamura; Kazuhito Shimazu; Youichiro Sugimoto; Tetsuro Takase; Minamimoto Ryogo; Michiaki Hiroe
Journal:  ESC Heart Fail       Date:  2018-02-05

6.  Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis.

Authors:  Dominik Roth; Nikolaos Kadoglou; Mariska Leeflang; Rene Spijker; Harald Herkner; Marialena Trivella
Journal:  Diagn Progn Res       Date:  2020-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.